These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8183234)

  • 1. Epibatidine, a potent analgetic and nicotinic agonist.
    Badio B; Daly JW
    Mol Pharmacol; 1994 Apr; 45(4):563-9. PubMed ID: 8183234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity.
    Rupniak NM; Patel S; Marwood R; Webb J; Traynor JR; Elliott J; Freedman SB; Fletcher SR; Hill RG
    Br J Pharmacol; 1994 Dec; 113(4):1487-93. PubMed ID: 7889306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epibatidine is a nicotinic analgesic.
    Qian C; Li T; Shen TY; Libertine-Garahan L; Eckman J; Biftu T; Ip S
    Eur J Pharmacol; 1993 Dec; 250(3):R13-4. PubMed ID: 8112391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine.
    Bonhaus DW; Bley KR; Broka CA; Fontana DJ; Leung E; Lewis R; Shieh A; Wong EH
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1199-203. PubMed ID: 7891333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
    Sullivan JP; Decker MW; Brioni JD; Donnelly-Roberts D; Anderson DJ; Bannon AW; Kang CH; Adams P; Piattoni-Kaplan M; Buckley MJ
    J Pharmacol Exp Ther; 1994 Nov; 271(2):624-31. PubMed ID: 7965777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
    Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
    Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 1995 Aug; 274(2):771-82. PubMed ID: 7543571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
    Houghtling RA; Dávila-García MI; Kellar KJ
    Mol Pharmacol; 1995 Aug; 48(2):280-7. PubMed ID: 7651361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological effects of epibatidine optical enantiomers.
    Damaj MI; Creasy KR; Grove AD; Rosecrans JA; Martin BR
    Brain Res; 1994 Nov; 664(1-2):34-40. PubMed ID: 7895043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heterocyclic substituted pyridine derivative (+/-)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors.
    Bencherif M; Schmitt JD; Bhatti BS; Crooks P; Caldwell WS; Lovette ME; Fowler K; Reeves L; Lippiello PM
    J Pharmacol Exp Ther; 1998 Mar; 284(3):886-94. PubMed ID: 9495846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine.
    Badio B; Garraffo HM; Plummer CV; Padgett WL; Daly JW
    Eur J Pharmacol; 1997 Feb; 321(2):189-94. PubMed ID: 9063687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study.
    Perry DC; Kellar KJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1030-4. PubMed ID: 7473129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
    Mellon RD; Bayer BM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epibatidine, an alkaloid from the poison frog Epipedobates tricolor, is a powerful ganglionic depolarizing agent.
    Fisher M; Huangfu D; Shen TY; Guyenet PG
    J Pharmacol Exp Ther; 1994 Aug; 270(2):702-7. PubMed ID: 8071862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epibatidine: high potency and broad spectrum activity on neuronal and neuromuscular nicotinic acetylcholine receptors.
    Lembeck F
    Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):378-85. PubMed ID: 10498287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity binding of epibatidine to serotonin type 3 receptors.
    Drisdel RC; Sharp D; Henderson T; Hales TG; Green WN
    J Biol Chem; 2008 Apr; 283(15):9659-65. PubMed ID: 17702741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug.
    Cucchiaro G; Xiao Y; Gonzalez-Sulser A; Kellar KJ
    Anesthesiology; 2008 Sep; 109(3):512-9. PubMed ID: 18719450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain.
    Marks MJ; Smith KW; Collins AC
    J Pharmacol Exp Ther; 1998 Apr; 285(1):377-86. PubMed ID: 9536034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine.
    Marutle A; Warpman U; Bogdanovic N; Nordberg A
    Brain Res; 1998 Aug; 801(1-2):143-9. PubMed ID: 9729344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [125/123I]IPH: a radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors.
    Musachio JL; Villemagne VL; Scheffel U; Stathis M; Finley P; Horti A; London ED; Dannals RF
    Synapse; 1997 Aug; 26(4):392-9. PubMed ID: 9215598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.